SCOTTI, VIERI
 Distribuzione geografica
Continente #
NA - Nord America 1.946
EU - Europa 923
AS - Asia 284
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.155
Nazione #
US - Stati Uniti d'America 1.943
PL - Polonia 274
IT - Italia 209
IE - Irlanda 188
SE - Svezia 141
HK - Hong Kong 115
CN - Cina 72
JO - Giordania 52
DE - Germania 35
FI - Finlandia 26
SG - Singapore 17
RU - Federazione Russa 14
GB - Regno Unito 12
IN - India 10
TR - Turchia 8
VN - Vietnam 6
BG - Bulgaria 5
ES - Italia 4
CA - Canada 3
FR - Francia 3
JP - Giappone 3
NL - Olanda 3
BE - Belgio 2
CH - Svizzera 2
LT - Lituania 2
UA - Ucraina 2
EG - Egitto 1
EU - Europa 1
GR - Grecia 1
PH - Filippine 1
Totale 3.155
Città #
Fairfield 364
Warsaw 274
Dublin 188
Chandler 184
Woodbridge 158
Ashburn 154
Seattle 143
Cambridge 129
Wilmington 126
Houston 122
Hong Kong 84
Lawrence 65
Altamura 64
Florence 55
Beijing 50
Princeton 45
Ann Arbor 38
Buffalo 38
Medford 24
Boston 22
San Diego 18
New York 16
Boardman 15
Kent 15
Falls Church 13
Jacksonville 12
Moscow 12
Shanghai 9
Pune 7
Rome 7
Dearborn 6
Hillsboro 6
Izmir 6
Munich 6
Singapore 6
Guangzhou 5
Milan 5
Sofia 5
Barcelona 4
Dong Ket 4
West Jordan 4
London 3
Norwalk 3
Pisa 3
Pontedera 3
Taranto 3
Andover 2
Bern 2
Brussels 2
Civitella del Tronto 2
Dallas 2
Fremont 2
Laurel 2
Misano Adriatico 2
Nagold 2
Nanjing 2
Nürnberg 2
Palombara Sabina 2
Paris 2
Pelago 2
Phoenix 2
Redwood City 2
Salerno 2
San Francisco 2
Somma Vesuviana 2
Stein 2
Toronto 2
Vilnius 2
Wuxi 2
Ankara 1
Aprilia 1
Atlanta 1
Bari 1
Busto Arsizio 1
Böblingen 1
Castelnuovo Berardenga 1
Chicago 1
Chongqing 1
Council Bluffs 1
Delhi 1
Enfield 1
Garden City 1
Gardone Val Trompia 1
Gate City 1
Guildford 1
Hefei 1
Ismailia 1
Kagoshima 1
Kumar 1
Kyiv 1
Leawood 1
Los Angeles 1
Mcallen 1
Montemurlo 1
New Bedfont 1
Prescot 1
Pullach im Isartal 1
Quezon City 1
Ragusa 1
Redmond 1
Totale 2.600
Nome #
Postmastectomy radiotherapy for locally advanced breast cancer receiving neoadjuvant chemotherapy. 205
Multiple cutaneous angiosarcomas after breast conserving surgery and bilateral adjuvant radiotherapy: an unusual case and review of the literature. 192
Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial 138
Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial 114
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study 113
External accelerated partial breast irradiation for ductal carcinoma in situ: long-term follow-up from a phase 3 randomized trial 105
Ribociclib plus letrozole and concomitant palliative radiotherapy for metastatic breast cancer 99
Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial 96
Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial 94
Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer 93
Adjuvant trastuzumab in breast cancer: experience from the University of Florence. 89
Doxorubicin and cyclophosphamideversus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvantchemotherapy in breast cancer. 88
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 86
91P * DEFINITIVE CONCOMITANT RADIOCHEMOTHERAPY (RCT) TREATMENT FOR LOCALLY ADVANCED (LA) NON SMALL CELL LUNG CANCER (NSCLC): EVALUATION OF HEMATOLOGICAL AND ESOPHAGEAL TOXICITY IN THE RADIATION ONCOLOGY DEPARTMENT OF UNIVERSITY OF FLORENCE EXPERIENCE 86
Prognostic role of human epidermal growth factor receptor 2 status in premenopausal early breast cancer treated with adjuvant tamoxifen. 85
76P THE IMPACT OF A BREATHING-CONTROL SYSTEM ON TARGET MARGINS AND NORMAL TISSUE SPARING IN THE TREATMENT OF LUNG CANCER: ANALYSIS OF 12 CASES AT RADIOTHERAPY UNIT OF FLORENCE UNIVERSITY 84
Application of helical tomotherapy for the treatment of a right atrium angiosarcoma: A case report 83
Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility 80
Predictive factors for additional non-sentinel lymph node involvement in breast cancer patients with one positive sentinel node 80
Accelerated Partial Breast Irradiation with IMRT: New Technical Approach and Interim Analysis of Acute Toxicity in a Phase III Randomized Clinical Trial. 79
Neoadjuvant oxaliplatin and 5-fluorouracil with concurrent radiotherapy in patients with locally advanced rectal cancer: a singleinstitution experience. 78
Safety of eribulin mesylate and concomitant radiotherapy for metastatic breast cancer: a single-center experience 77
Impact of a breathing-control system on target margins and normal-tissue sparing in the treatment of lung cancer: experience at the radiotherapy unit of Florence University. 72
Impact of sentinel node tumor burden on outcome of invasive breast cancer patients. 70
Post-operative radiotherapy in N2 non-small cell lung cancer: a retrospective analysis of 175 patients. 68
Isolated chest wall implantation of non-small cell lung cancer after fine-needle aspiration: a case report and review of the literature. 67
Impact of age on cytotoxic-induced ovarian failure in breast cancer treated with adjuvant chemotherapy and triptorelin 66
Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial 64
The impact of young age on breast cancer outcome 62
Vinorelbine-based chemo-radiotherapy in non-small cell lung cancer. 54
Radiotherapy timing in the treatment of limited-stage small cell lung cancer: the impact of thoracic and brain irradiation on survival. 48
Impact of COVID-19 on workload burden of a complex radiotherapy facility 43
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO 38
Postoperative radiotherapyin stage I/II endometrial cancer: retrospective analysis of 883 patients treated at the University of Florence. 38
Correction to: Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility (Supportive Care in Cancer, (2021), 29, 6, (2931-2937), 10.1007/s00520-020-05793-3) 37
Cardioprotective Strategy for Patients with Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial 36
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833) 35
Is there a worthwhile value in personalizing radiation therapy for breast cancer patients? Time for a new paradigm in the older adult population 34
Pembrolizumab for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Analysis of Prognostic Factors of Outcomes 28
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy 27
Update chemotherapy schedule in the treatment of lung cancer 21
Lobectomy vs Stereotactic Ablative Radiotherapy in NSCLC: a multicentric series in four centers 21
The impact of patient preference in the treatment algorithm for recurrent/metastatic head and neck squamous cell carcinoma 17
Quitting Smoking At or Around Diagnosis Improves the Overall Survival of Lung Cancer Patients: A Systematic Review and Meta-Analysis 14
Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression 10
Totale 3.214
Categoria #
all - tutte 10.899
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.899


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019229 0 0 0 0 0 0 0 0 0 0 116 113
2019/2020718 51 39 16 55 92 91 82 84 80 61 52 15
2020/2021363 32 24 17 51 13 22 16 26 37 73 38 14
2021/2022304 4 15 20 15 17 20 11 17 18 12 58 97
2022/2023839 67 199 34 37 59 149 103 49 109 5 15 13
2023/2024378 12 32 46 14 24 70 24 107 6 28 15 0
Totale 3.214